Literature DB >> 3024409

Infection of the HTLV-II-bearing T-cell line C3 with HTLV-III/LAV is highly permissive and lytic.

D C Montefiori, W M Mitchell.   

Abstract

The recent discovery that HTLV-I infected T-cells have an enhanced susceptibility to HTLV-III/LAV infection with concurrent cell lysis (S. Harada, Y. Koyanagi, and N. Yamamoto (1985) Science, 229, 563-566) led us to investigate a possible role for HTLV-II infected T cells in this respect. HTLV-II-bearing C3 cells were exposed to HTLV-III/LAV and the subsequent infection monitored by indirect immunofluorescence (IIF) of cells, reverse transcriptase (RT) activity in culture fluids, and hemacytometer cell counts. HTLV-III/LAV antigen expression was detected within 2 days whereas RT activity was detected within 3 days postinfection. The presence of immunofluorescent positive cells and RT activity was accompanied by cell lysis. Double infection of C3 cells was confirmed by IIF using a goat polyclonal antibody directed against the core p24 protein for detecting HTLV-II, and high titer serum from a pre-AIDS patient for detecting HTLV-III/LAV. We conclude that HTLV-I and HTLV-II infected T-cells share an enhanced susceptibility to HTLV-III/LAV infection with the promotion of cell lysis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3024409     DOI: 10.1016/0042-6822(86)90233-3

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  Concomitant infection of HTLV-I and HIV-1: prevalence of IgG and IgM antibodies in Washington, D.C. area.

Authors:  K S Chang; L C Wang; C L Gao; S Alexander; R C Ting; A Bodner; T Log; A F Kuo; P Strickland
Journal:  Eur J Epidemiol       Date:  1988-12       Impact factor: 8.082

2.  Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees.

Authors:  W E Robinson; D C Montefiori; W M Mitchell; A M Prince; H J Alter; G R Dreesman; J W Eichberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

3.  Antiviral activity of mismatched double-stranded RNA against human immunodeficiency virus in vitro.

Authors:  D C Montefiori; W M Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

4.  Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1.

Authors:  D C Montefiori; W E Robinson; W M Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay.

Authors:  D C Montefiori; W E Robinson; S S Schuffman; W M Mitchell
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

6.  CD4-independent binding of HIV-1 to the B lymphocyte receptor CR2 (CD21) in the presence of complement and antibody.

Authors:  D C Montefiori; J Zhou; D I Shaff
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.